TP53 mutation
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
TP53 mutation
Oct 16, 2024, 17:41 |
Insight
Hans Hofland: Can NET become NEC (-like)?
Hans Hofland shared a post on X about a recent paper by Atsuko Kasajima et al.…
Jun 21, 2024, 05:08 |
Insight
Enrique Grande: A Molecular-Directed Strategy with TP53 Mutation in small cell bladder cancer
Enrique Grande, Head of Oncology at MD Anderson Madrid Cancer Center, recently shared a post…
Jun 18, 2024, 23:17 |
Insight
Talha Badar: TP53 mutation in Myeloproliferative neoplasms
Talha Badar shared on X: , "Genomic landscape, impact allelic burden, time to…
Jun 15, 2024, 05:45 |
Blog
Mohammad Jad Moussa: Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared a post…
May 18, 2024, 14:13 |
Blog
Sanam Loghavi: A picture (or 3) is worth a thousand words
Sanam Loghavi posted on X: “A picture (or 3) worth a thousand words. TP53-mutation acute…
May 18, 2024, 01:19 |
Insight
Simona Cristea: The progress of cancer genetics
Simona Cristea, Head of Data Science at Hale Center for Pancreatic Cancer, made the following…
All:
6
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube